Core Viewpoint - Jia Hua Co., Ltd. reported a decline in revenue but an increase in profit for the first half of 2025, indicating a mixed performance in its operations [1][3]. Financial Performance - The company achieved an operating revenue of 681 million yuan, a year-on-year decrease of 12.86% [1]. - The net profit attributable to shareholders was 62 million yuan, reflecting a year-on-year growth of 7.79% [1]. - The net profit margin improved from 7.39% in the first half of 2024 to 9.15% in 2025 [3]. - The gross profit margin increased from 13.20% to 16.00% [3]. - The return on equity was 5.64%, with a year-on-year increase of 0.12 percentage points, indicating overall improvement in profitability quality [3]. Operational Efficiency - The inventory turnover days increased to 71.22 days, up by 11.22% compared to the first half of 2024, suggesting increased pressure on inventory management [5]. - The net cash flow from operating activities was 4 million yuan, a significant decline from 54 million yuan in the same period of 2024 [5]. - The debt-to-asset ratio for the first half of 2025 was 17.89%, a decrease of 5.59 percentage points year-on-year, indicating a lighter debt burden and a more stable financial structure [5]. Institutional Holdings - As of the first half of 2025, the number of institutions holding Jia Hua Co., Ltd. shares decreased to 3, down from 50 in the same period of 2024, showing a significant decline in institutional investor participation [7]. - The company's market capitalization peaked at 4.015 billion yuan on September 19, 2022, while the current market cap stands at 2.370 billion yuan, indicating a need for a 69.44% increase in stock price to reach its historical high [7]. - Despite the decline in institutional interest, the company has shown positive changes in profitability quality and financial structure [7].

证券代码：603182 证券简称：嘉华股份 公告编号：2025-019 山东嘉华生物科技股份有限公司 2025 年半年度主要经营数据公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 根据《上海证券交易所上市公司自律监管指引第 3 号行业信息披露：第十四 号——食品制造》的相关要求，山东嘉华生物科技股份有限公司（以下简称"公 司"）现将 2025 年半年度主要经营数据公告如下： | | | 单位：万元 | | --- | --- | --- | | 项目 | 金额 | 比例（%） | | 大豆蛋白 | 39,554.66 | 58.23 | | 大豆油 | 14,944.04 | 22.00 | | 大豆膳食纤维 | 4,158.90 | 6.12 | | 低温食用豆粕 | 2,426.80 | 3.57 | | 蒸汽 | 3,115.44 | 4.59 | | 电力 | 1,666.80 | 2.45 | | 副产品 | 2,067.26 | 3.04 | | 合计 | 67,933.90 | 100.00 | 一、按产品 ...

证券代码：603182 证券简称：嘉华股份 公告编号：2025-013 山东嘉华生物科技股份有限公司 2025 年第一季度主要经营数据公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 根据《上海证券交易所上市公司自律监管指引第 3 号行业信息披露：第十四 号——食品制造》的相关要求，山东嘉华生物科技股份有限公司（以下简称"公 司"）现将 2025 年第一季度主要经营数据公告如下： | 项目 | 金额 | 比例（%） | | --- | --- | --- | | 大豆蛋白 | 19,867.28 | 57.33 | | 大豆油 | 7,158.68 | 20.66 | | 大豆膳食纤维 | 2,404.70 | 6.94 | | 低温食用豆粕 | 1,293.57 | 3.73 | | 蒸汽 | 2,022.53 | 5.84 | | 电力 | 847.35 | 2.45 | | 副产品 | 1,059.51 | 3.05 | | 合计 | 34,653.62 | 100.00 | 一、按产品类别分类的销售情况 单位：万元 ...